Literature DB >> 29594798

Improved quality of care for patients infected or colonised with ESBL-producing Enterobacteriaceae in a French teaching hospital: impact of an interventional prospective study and development of specific tools.

Véronique Mondain1, Florence Lieutier2, Céline Pulcini3, Nicolas Degand4, Luce Landraud4, Raymond Ruimy4, Thierry Fosse5, Pierre Marie Roger3.   

Abstract

The increasing incidence of ESBL-producing Enterobacteriaceae (ESBL-E) in France prompted the publication of national recommendations in 2010. Based on these, we developed a toolkit and a warning system to optimise management of ESBL-E infected or colonised patients in both community and hospital settings. The impact of this initiative on quality of care was assessed in a teaching hospital. The ESBL toolkit was developed in 2011 during multidisciplinary meetings involving a regional network of hospital, private clinic and laboratory staff in Southeastern France. It includes antibiotic treatment protocols, a check list, mail templates and a patient information sheet focusing on infection control. Upon identification of ESBL-E, the warning system involves alerting the attending physician and the infectious disease (ID) advisor, with immediate, advice-based implementation of the toolkit. The procedure and toolkit were tested in our teaching hospital. Patient management was compared before and after implementation of the toolkit over two 3-month periods (July-October 2010 and 2012). Implementation of the ESBL-E warning system and ESBL-E toolkit was tested for 87 patients in 2010 and 92 patients in 2012, resulting in improved patient management: expert advice sought and followed (16 vs 97%), information provided to the patient's general practitioner (18 vs 63%) and coding of the condition in the patient's medical file (17 vs 59%), respectively. Our multidisciplinary strategy improved quality of care for in-patients infected or colonised with ESBL-E, increasing compliance with national recommendations.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29594798     DOI: 10.1007/s10096-018-3234-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Ongoing increasing temporal and geographical trends of the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae infections in France, 2009 to 2013.

Authors:  Isabelle Arnaud; Sylvie Maugat; Vincent Jarlier; Pascal Astagneau
Journal:  Euro Surveill       Date:  2015

Review 2.  Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis.

Authors:  Giulia De Angelis; Maria Adriana Cataldo; Chiara De Waure; Silvia Venturiello; Giuseppe La Torre; Roberto Cauda; Yehuda Carmeli; Evelina Tacconelli
Journal:  J Antimicrob Chemother       Date:  2014-01-23       Impact factor: 5.790

3.  Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

Authors:  Jean-Ralph Zahar; Philippe Lesprit; Stephane Ruckly; Aurelia Eden; Hitoto Hikombo; Louis Bernard; Stephan Harbarth; Jean-François Timsit; Christian Brun-Buisson
Journal:  Int J Antimicrob Agents       Date:  2016-11-16       Impact factor: 5.283

4.  Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria.

Authors:  Guillaume Kac; Patrick Grohs; Pierre Durieux; Ludovic Trinquart; Mathilde Gueneret; Aurelia Rodi; Pierre Boiron; Romain Guillemain; Jacques Leglise; Guy Meyer
Journal:  Arch Intern Med       Date:  2007-10-22

5.  Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs.

Authors:  J A Maslikowska; S A N Walker; M Elligsen; N Mittmann; L Palmay; N Daneman; A Simor
Journal:  J Hosp Infect       Date:  2015-10-22       Impact factor: 3.926

6.  Long-term faecal carriage in infants and intra-household transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak.

Authors:  Iren Høyland Löhr; Siren Rettedal; Olav B Natås; Umaer Naseer; Knut Oymar; Arnfinn Sundsfjord
Journal:  J Antimicrob Chemother       Date:  2013-01-03       Impact factor: 5.790

7.  Hospital cross-transmission of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.

Authors:  P Cholley; M Thouverez; H Gbaguidi-Haore; M Sauget; C Slekovec; X Bertrand; D Talon; D Hocquet
Journal:  Med Mal Infect       Date:  2013-07-19       Impact factor: 2.152

Review 8.  Overcoming the obstacles of implementing infection prevention and control guidelines.

Authors:  G Birgand; A Johansson; E Szilagyi; J-C Lucet
Journal:  Clin Microbiol Infect       Date:  2015-09-11       Impact factor: 8.067

9.  Living with extended-spectrum β-lactamase: a qualitative study of patient experiences.

Authors:  Susanne Wiklund; Ulrika Hallberg; Gunnar Kahlmeter; Ann Tammelin
Journal:  Am J Infect Control       Date:  2013-02-09       Impact factor: 2.918

10.  First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs.

Authors:  Xiaojun Ma; Yinghong Wu; Liuyi Li; Qian Xu; Bijie Hu; Yuxing Ni; Anhua Wu; Shumei Sun; Vincent Jarlier; Jérôme Robert
Journal:  BMC Infect Dis       Date:  2015-08-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.